Tracheotomy in patients with acquired immunodeficiency syndrome. Is it necessary? NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Tracheotomy in patients with acquired immunodeficiency syndrome. Is it necessary?

Arch Otolaryngol Head Neck Surg. 1994 Oct;120(10):1126-9. Unique Identifier : AIDSLINE MED/95000523
Thomas GR; Myers EM; Nunez A; Department of Otolaryngology-Head and Neck Surgery, Georgetown; University School of Medicine, Washington, DC.

Abstract: OBJECTIVE: Patients with acquired immunodeficiency syndrome (AIDS) who develop respiratory failure and require mechanical ventilation have mortality rates of 85%. Tracheotomies are performed in this patient population for prolonged intubation. However, to date, objective data on tracheotomy in patients with AIDS are lacking. Tracheotomy in ventilator-dependent patients with AIDS presents risks to patients and exposes surgeons, nurses, and operating room personnel to human immunodeficiency virus-infected blood. DESIGN: Given these considerations, we retrospectively reviewed our experience with tracheotomy in 10 intubated and ventilator-dependent patients with AIDS. CONCLUSIONS: Our study shows a mortality rate of 100%. We identify predictive factors and a prognosis that may aid in the treatment of these patients.
Keywords: Acquired Immunodeficiency Syndrome/*COMPLICATIONS Adult Age Factors Cause of Death Emergencies Female Human Kidney Failure/COMPLICATIONS Length of Stay Liver Failure/COMPLICATIONS Male Middle Age Multiple Organ Failure/COMPLICATIONS Oxygen/BLOOD Patient Admission Respiratory Insufficiency/DIAGNOSIS/*SURGERY Retrospective Studies Shock, Septic/DIAGNOSIS *Tracheotomy Tuberculosis, Meningeal/DIAGNOSIS JOURNAL ARTICLEKWDacquiredimmunodeficiencysyndrome/
950130
M9510854

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .